Cargando…
Utility and Safety of Perampanel in Pediatric FIRES and Other Drug-Resistant Epilepsies
Perampanel is a novel antiepileptic drug, which antagonises AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) glutamate receptor. We describe perampanel as an adjunctive treatment for FIRES (febrile infection-related epilepsy syndrome) and other drug-resistant epilepsies. A single-cent...
Autores principales: | Lim, Guo Yong, Chen, Chun Liang, Chan Wei Shih, Derrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606971/ https://www.ncbi.nlm.nih.gov/pubmed/34820471 http://dx.doi.org/10.1177/2329048X211055335 |
Ejemplares similares
-
Current role of perampanel in pediatric epilepsy
por: De Liso, Paola, et al.
Publicado: (2017) -
Efficacy of perampanel as an adjunctive therapy in pediatric focal epilepsy
por: Zhang, Wei-Ran, et al.
Publicado: (2023) -
New drug classes for the treatment of partial onset epilepsy: focus on perampanel
por: Shih, Jerry J, et al.
Publicado: (2013) -
Efficacy of perampanel in pediatric epilepsy with known and presumed genetic etiology
por: Miao, Pu, et al.
Publicado: (2023) -
Initial therapeutic target attainment of perampanel in pediatric patients with epilepsy
por: Yu, Lingyan, et al.
Publicado: (2023)